Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorLund University Hospital
About this trial
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Eligibility criteria
Qualifiers
Age 18-100 years
Histologically confirmed (according to the World Health Organization (WHO)/EORTC classification) MF/SS stages I-IV
WHO performance status 0 -3
Absence of psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov